A nicotine gum with your own brand?
Learn more about our superior nicotine gum and how it is adapted to fit a market with huge potential.
FOR MORE INFORMATION
The ChewMed® platform offers unique possibilities
Realize the benefits of our technology for development of active gums.
FOR MORE INFORMATION
Let us develop your medicated gum application together
Learn more about how to become a partner and what´s in our pipeline.
FOR MORE INFORMATIONInterested in collaboration?
Enorama Pharma submits proposed supplements on the MAA to the Swedish MPA
The supplements was minor editorial changes and Enorama now enters the final stage of the MAA process.
READ MORE
Enorama Pharma's pathway towards a medical cannabis chewing gum
Enorama Pharma believes that there will be a great need for serious cannabis products in the future.
READ MOREWhat does it mean to grant discharge at the annual general meeting?
Micael Karlsson, lawyer and partner at lawfirm Delphi, explains.
Trump administration strips India of special trade status and preferential market access
This decision does not affect Enorama Pharma's ongoing development work in India.
READ MORE
The Greek market for smoking cessation products is growing and so is the interest in nicotine gum
Enorama Pharma travels to Athens to meet several potential customers.
READ MORE
New elections are proposed to the Board of Enorama Pharma: Bengt Jönsson and Anders Dahlin
Two extremely meritorious contributions to Enorama Pharma's Board of Directors.
READ MORE
Enorama Pharma in collaboration with cannabis expert Dr. Arno Hazekamp
Enorama initiates a collaboration with Dr. Hazekamp to benefit from his expertise within cannabis.
READ MORE
Enorama Pharma participates at the European Cannabis Symposium May 6 2019
MJBizDaily’s European Cannabis Symposium gathers leaders within Europe’s medical cannabis markets.
READ MORE
Oral nicotine products provide safer distribution of nicotine by avoiding harmful inhalation
Enorama's new unit for nicotine products, non-pharmaceuticals, works with oral nicotine.
READ MORE
Enorama Pharma submits additions on the MAA to the Swedish Medical Products Agency
These applications are a first step towards the approval of the products in the EU.
READ MORE
Enorama Pharma establishes a development lab for medicinal cannabis
The Company establishes a development laboratory at Malmö University's Open Lab, Sweden.
READ MORE
Enorama Pharma enters into agreement within Cough & Cold
In February 2019, Enorama Pharma entered into an agreement with the company MediiGum LLC.
Enorama Pharma enters into agreement within Cough & Cold
Enorama Pharma receives permission to handle cannabis
The permit means that the Company can now begin developing a chewing gum with medical cannabis.
READ MORE
Enorama Pharmas preferential rights issue oversubscribed
152%! We reached our goal with good margin. The preferential rights issue oversubscribed.
READ MOREEnorama Pharma has received a Wholesale License
Enorama now has all the approvals required to apply for registration of medical products in Europe.
READ MORE